Summary : –Japanese pharma Eisai has backed away from its 50:50 profit-sharing arrangement with Biogen…
Tag:
Regulators
-
-
Summary The U.S. Centers for Medicare & Medicaid Services (CMS) just completed the open comment…
-
BiogenChemIntelligenceGlobal Market
Biogen’s Aduhelm Grabs the Spotlight at User Fee Renewals Hearing
by adminSummary – The House Energy and Commerce Committee’s health panel met to discuss renewing user…
-
ChemIntelligenceGlobal Market
Biogen, Eisai face Down Another Aduhelm Refusal—this Time from Japanese Regulators
by adminSynopsis: After a special meeting, the Japanese drug reviewers ruled that existing data didn’t support…
-
ChemIntelligenceMefenoxam
Albaugh’s Anchor 3L ST (Metalaxyl-M) Fungicide Seed Treatment Launched in US Seed Treatment Market.
by adminKeypoints Albaugh announced the EPA registration of Anchor™ 3L ST in multiple crop segments as…